UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A rule-free workflow for the automated generation of databases from scientific literature

npj computational materials, 2023-12, Vol.9 (1), p.222-222, Article 222

2023

Volltextzugriff (PDF)

Author Correction: A rule-free workflow for the automated generation of databases from scientific literature

npj computational materials, 2024-01, Vol.10 (1), p.4-2, Article 4

2024

Volltextzugriff (PDF)

Does salmon calcitonin cause cancer? A review and meta-analysis

Osteoporosis international, 2016-01, Vol.27 (1), p.13-19

2016

Volltextzugriff (PDF)

Does salmon calcitonin cause cancer? A review and meta-analysis

Osteoporosis international, 2016-01, Vol.27 (1), p.13-19

2016

Volltextzugriff (PDF)

Respirators and surgical facemasks for COVID-19: implications for MRI

Clinical radiology, 2020-06, Vol.75 (6), p.405-407

2020

Volltextzugriff (PDF)

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial

Osteoporosis international, 2014-11, Vol.25 (11), p.2649-2656

2014

Volltextzugriff (PDF)

Calcitonin for osteoporosis and bone pain

Current pharmaceutical design, 2003-12, Vol.9 (32), p.2659-2676

2003

Volltextzugriff (PDF)

Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats

Bone (New York, N.Y.), 1997-09, Vol.21 (3), p.269-274

1997

Volltextzugriff (PDF)

Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies

Journal of medicinal chemistry, 1999-03, Vol.42 (5), p.819-832

1999

Volltextzugriff (PDF)

Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems : In vitro permeability and in vivo oral absorption of salmon calcitonin (sCT)

Pharmaceutical research, 1999-04, Vol.16 (4), p.527-533

1999

Volltextzugriff (PDF)

Corticotropin Releasing Factor (CRF) Receptor Modulators: Progress and Opportunities for New Therapeutic Agents

Journal of medicinal chemistry, 2000-05, Vol.43 (9), p.1641-1660

2000

Volltextzugriff (PDF)

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Journal of bone and mineral research, 2012-08, Vol.27 (8), p.1821-1829

2012

Volltextzugriff (PDF)

Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

Bioorganic & medicinal chemistry letters, 1999-04, Vol.9 (7), p.967-972

1999

Volltextzugriff (PDF)

Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

Bioorganic & medicinal chemistry letters, 1999-04, Vol.9 (8), p.1185-1188

1999

Volltextzugriff (PDF)

DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles

The Journal of pharmacology and experimental therapeutics, 1992-12, Vol.263 (3), p.1167

1992

Volltextzugriff (PDF)

MRI safety management in patients with cardiac implantable electronic devices: Utilizing failure mode and effects analysis for risk optimization

International journal for quality in health care, 2020-09, Vol.32 (7), p.431-437

2020

Volltextzugriff (PDF)

Structure–activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists

Bioorganic & medicinal chemistry, 1999-11, Vol.7 (11), p.2321-2328

1999

Volltextzugriff (PDF)

4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists

Bioorganic & medicinal chemistry letters, 1999-04, Vol.9 (7), p.1057-1062

1999

Volltextzugriff (PDF)

Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

Journal of medicinal chemistry, 1992-11, Vol.35 (23), p.4344-4361

1992

Volltextzugriff (PDF)

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

Bioorganic & medicinal chemistry, 2000-01, Vol.8 (1), p.181-189

2000

Volltextzugriff (PDF)

Production of Recombinant Salmon Calcitonin by In Vitro Amidation of an Escherichia coli Produced Precursor Peptide

Bio/technology (New York, N.Y. 1983), 1993-01, Vol.11 (1), p.64-70

1993

Volltextzugriff (PDF)

Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide

The Journal of pharmacology and experimental therapeutics, 1989-12, Vol.251 (3), p.956

1989

Volltextzugriff (PDF)

Piperidinyltetralin .sigma. Ligands

Journal of medicinal chemistry, 1994-02, Vol.37 (3), p.364-370

1994

Volltextzugriff (PDF)

1 – 25 von 551

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(485)
Mit Volltextzugriff
(448)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(550)

Erscheinungsjahr

n.n

Thema

Science & Technology
(338)
Life Sciences & Biomedicine
(285)
Humans
(208)
Biological And Medical Sciences
(127)
Female
(108)
Male
(102)
Medical Sciences
(95)
Animals
(80)
Adult
(71)
Middle Aged
(66)
Physical Sciences
(56)
Aged
(48)
Microbiology
(46)
Rats
(43)
Pharmacology. Drug Treatments
(41)
Pharmacology & Pharmacy
(39)
Adolescent
(37)
Fundamental And Applied Biological Sciences. Psychology
(35)
Chemistry
(33)
Chemistry, Medicinal
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A rule-free workflow for the automated generation of databases from scientific literature

Author Correction: A rule-free workflow for the automated generation of databases from scientific literature

Does salmon calcitonin cause cancer? A review and meta-analysis

Does salmon calcitonin cause cancer? A review and meta-analysis

Respirators and surgical facemasks for COVID-19: implications for MRI

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial

Calcitonin for osteoporosis and bone pain

Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats

Non-Peptide Corticotropin-Releasing Hormone Antagonists: Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines

Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies

Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines

Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems : In vitro permeability and in vivo oral absorption of salmon calcitonin (sCT)

Corticotropin Releasing Factor (CRF) Receptor Modulators: Progress and Opportunities for New Therapeutic Agents

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles

MRI safety management in patients with cardiac implantable electronic devices: Utilizing failure mode and effects analysis for risk optimization

Structure–activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists

4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists

Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

Production of Recombinant Salmon Calcitonin by In Vitro Amidation of an Escherichia coli Produced Precursor Peptide

Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide

Piperidinyltetralin .sigma. Ligands

Suchergebnisse filtern